Using Blinatumomab in Acute Lymphoblastic Leukemia

0 Views
administrator
administrator
06/15/23

The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next